Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.99 USD | +3.99% | -0.51% | -7.48% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 37.48M |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.08
x | P/E ratio 2025 * |
-1.73
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 25.21% |
Latest transcript on MiNK Therapeutics, Inc.
1 day | +3.99% | ||
1 week | -0.49% | ||
Current month | +2.06% | ||
1 month | +10.00% | ||
3 months | +2.91% | ||
6 months | -2.94% | ||
Current year | -7.48% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 17-06-30 |
Director/Board Member | 66 | 17-06-30 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 0.99 | +3.99% | 12,577 |
24-06-10 | 0.952 | -1.27% | 36,241 |
24-06-07 | 0.9642 | -1.61% | 45,976 |
24-06-06 | 0.98 | -2.00% | 40,825 |
24-06-05 | 1 | +0.49% | 51,779 |
Delayed Quote Nasdaq, June 11, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.48% | 37.48M | |
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |
- Stock Market
- Equities
- INKT Stock